NSC |
Compound |
Enrichment |
Correlation |
NSC 712001 |
Null |
0.0293341670043648 |
-0.074306305 |
NSC 724631 |
4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione |
0.0309214021749421 |
0.070854909 |
NSC 741942 |
Null |
0.0309214021749421 |
0.0086035597 |
NSC 756166 |
GSK312948A |
0.0309214021749421 |
0.27498015 |
NSC 756251 |
GW559768X |
0.0309214021749421 |
-0.13703765 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0309214021749421 |
0.095296167 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0309214021749425 |
-0.050542691 |
NSC 295641 |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.0309214021749425 |
0.29127517 |
NSC 324368 |
3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide |
0.0309214021749425 |
0.041652997 |
NSC 329226 |
42179 |
0.0309214021749425 |
0.13245621 |